Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial

Cutis

Volumn 74, Issue 2, 2004, Pages

  Theos, Amy U ^a   Cummins, Rebecca ^b   Silverberg, Nanette B ^c   Paller, Amy S ^b,d,e  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d 3M COMPANY   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVALUATION; FEMALE; HUMAN; MALE; MOLLUSCUM CONTAGIOSUM; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; STATISTICAL ANALYSIS; TIME SERIES ANALYSIS;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MOLLUSCUM CONTAGIOSUM; OINTMENTS; PILOT PROJECTS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 19344376816     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol. 1994;33:453-461.
2. Cribier B, Scriverner Y, Grosshans E. Molluscum contagiosum: histologie patterns and associated lesions. a study of 578 cases. Am J Dermatol. 2001;23:99-103.
3. Hawley TG. The natural history of molluscum contagiosum in Fijian children. J Hyg (Lond). 1970;68:631-632.
4. Overfield TM, Brody JA. An epidemiologic study of molluscum contagiosum in Anchorage, Alaska. J Pediatr. 1966;69:640-642.
5. Janniger CK, Schwartz RA. Molluscum contagiosum in children. Pediatr Dermatol. 1993;52:194-196.
6. Syed TA, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. a placebo-controlled, double-blind study. Dermatology 1994;189:65-68.
7. Romiti R, Ribeiro AP, Grinblat BM, et al. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol. 1999;16:228-231.
8. Rönnerfält L, Fransson J, Wahlgren CF. EMLA cream provides rapid pain relief for the curettage of molluscum contagiosum in children with atopic dermatitis without causing serious application-site reactions. Pediatr Dermatol. 1998;15:309-312.
9. Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. 2000;43:503-507.
10. Niizeki K, Hashimoto K. Treatment of molluscum contagiosum with silver nitrate paste. Pediatr Dermatol. 1999;16:395-397.
11. Valentine CL, Diven D. Treatment modalities for molluscum contagiosum. Dermatol Ther. 2000;13:285-289.
12. Cunningham BB, Paller AS. Inefficacy of oral cimetidine for nonatopic children with molluscum contagiosum. Pediatr Dermatol 1998;15:71-72.
13. Imbertson LM, Beaurline JM, Couture AM, et al. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463. J Invest Dermatol. 1998;110:734-739.
14. Hengge UR, Esser S, Schultewolter T, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol. 2000;143:1026-1031.
15. Liota E, Smith KJ, Buckley R, et al. Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg. 2000;4:76-82.
16. Barba AR, Kapoor S, Berman B. An open label safety study of topical imiquimod 5% cream in the treatment of molluscum contagiosum in children [clinical trial]. Dermatol Online J. 2001;7:20.
17. Skinner RB Jr, Ray S, Talanin NY. Treatment of molluscum contagiosum with topical 5% imiquimod cream [letter]. Pediatr Dermatol. 2000;17:420.
18. Testerman TL, Gerster JF, Imbertson LM, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol. 1995;58:365-372.
19. Moresi JM, Herbert CR, Cohen BA. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream. Pediatr Dermatol. 2001;18:448-452.
20. Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol. 2002;19:263-266.
21. Shisler JL, Moss B. Molluscum contagiosum virus inhibitors of apoptosis: the MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology. 2001;282:14-25.
22. Xiang Y, Moss B. IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci U S A. 1999;96:11537-11542.
23. Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. J Am Acad Dermatol. 1992;27:583-588.
24. Calista D, Boschini A, Landi G. Resolution of disseminated molluscum contagiosum with highly active anti-retroviral therapy (HAART) in patients with AIDS. Eur J Dermatol. 1999;9:211-213.
25. Matis WL, Triana A, Shapiro R, et al. Dermatologic findings associated with human immunodeficiency virus infection. J Am Acad Dermatol. 1987;17(suppl 5, pt 1):746-751.
26. National guideline for the management of molluscum contagiosum. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect. 1999;75(suppl 1):S80-S81.
27. Weston WL, Lane AT. Should molluscum be treated [letter]? Pediatrics. 1980;65:865.